Profile for Ukraine Patent: 110354
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Ukraine Patent: 110354
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Nov 16, 2032 | Gilead Sciences Inc | VOSEVI | sofosbuvir; velpatasvir; voxilaprevir |
⤷ Sign Up | May 16, 2033 | Gilead Sciences Inc | EPCLUSA | sofosbuvir; velpatasvir |
⤷ Sign Up | May 16, 2033 | Gilead Sciences Inc | VOSEVI | sofosbuvir; velpatasvir; voxilaprevir |
⤷ Sign Up | May 16, 2033 | Gilead Sciences Inc | EPCLUSA | sofosbuvir; velpatasvir |
⤷ Sign Up | May 16, 2033 | Gilead Sciences Inc | VOSEVI | sofosbuvir; velpatasvir; voxilaprevir |
⤷ Sign Up | May 16, 2033 | Gilead Sciences Inc | EPCLUSA | sofosbuvir; velpatasvir |
⤷ Sign Up | May 16, 2033 | Gilead Sciences Inc | VOSEVI | sofosbuvir; velpatasvir; voxilaprevir |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |